Management and results of treatment of patients with refractory ovarian cancerr
https://doi.org/10.17650/1994-4098-2011-0-3-88-95
Abstract
The results of observation of 22 patients with refractory ovarian cancer were analyzed. The usefulness of chemotherapy the second and subsequent lines of treatment is shown. Sequential treatment by not cross-resistant chemotherapy allows increase median survival up to 12.5 months in general group. In 36 % of patients with good performance status prolonged stabilization of disease with median overall survival of 22.3 months was achieved.
About the Authors
N. G. Kormosh
Research Institute of Clinical Oncology of N.N. Blokchin Russian Cancer Research Center of Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
K. P. Laktionov
Research Institute of Clinical Oncology of N.N. Blokchin Russian Cancer Research Center of Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
References
1. Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2007 г. Вестник РОНЦ им. Н.Н. Блохина РАМН 2009; 20(3) (прил.1).
2. Кедрова А.Г. Персистирующий рак яичников: активная тактика лечения. Материалы X Российского онкологического конгресса. Москва, 2006.
Review
For citations:
Kormosh N.G., Laktionov K.P. Management and results of treatment of patients with refractory ovarian cancerr. Tumors of female reproductive system. 2011;(3):88-95. (In Russ.) https://doi.org/10.17650/1994-4098-2011-0-3-88-95
Views:
545
Email this article 